VKTX
Viking Therapeutics Inc
28.50$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +83.8% | +89.4% | -29.1% | -65.4% | -45.5% | +6.5% | +6.9% | -1.7% | +0.3% | +18.5% | +24.6% | |
| – | +41,470.0% | -31.0% | -19.1% | +79.7% | +43.5% | +55.4% | +4.8% | +42.2% | +93.1% | +77.4% | +37.4% | |
| – | – | -31.0% | -19.1% | +79.7% | +43.5% | +55.4% | +4.8% | +42.2% | – | – | – | |
| – | -97.2% | +37.0% | +108.4% | -53.5% | -559.7% | – | -137.9% | – | -65.2% | +163.9% | +423.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | -157.1% | +15,262.7% | – | +457.0% | -8.7% | +44.2% | -427.1% | +209.0% | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | +1,800.0% | +502.6% | -90.4% | +477.3% | +18.9% | +96.0% | +138.9% | +961,003.3% | +4.8% | +491.2% | – | |
| – | -103.8% | +0.0% | -18.6% | +4,861.1% | – | – | – | – | – | – | – | |
| – | +924.8% | -53.4% | +116.5% | +1,240.5% | -99.7% | +7.1% | +624.2% | -39.5% | +6,418.8% | +125.7% | -87.5% | |
| – | -97.8% | +18,075.0% | +156.3% | +167.1% | -203.9% | – | -113.2% | – | +84.0% | -252.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.